2022 US drug price rises high - but mostly not as high as inflation

Ohio-based 46brooklyn Research - a non-profit corporation that seeks to improve the accessibility and usability of US drug pricing data - has delivered its latest report on what Americans are paying for their medicines.

While the January 2023 brand list price rises recorded so far have not been as significant as in the last couple of years, according to the findings, the increases in 2022 as a whole were at a level only exceeded in 2015.

"We’re entering a brave new world"Another important metric is how much prices have increased by. The weighted average, based on Medicaid utilization data, increased last year compared to the 2021 rise. This year the jump was nearly 7%, a rate not seen since 2018.